Skip to main content
. 2015 Nov 10;2015:382652. doi: 10.1155/2015/382652

Figure 5.

Figure 5

O-GlcNAc western blot of young and senescent HPMC treated with modulators of the hexosamine biosynthesis pathway (HBP). (a) Representative O-GlcNAc specific western blot of young (left) and senescent (right) human peritoneal mesothelial cells (HPMC) treated with O-GlcNAcylation inhibitor (DON) or an inhibitor of the O-GlcNAcase (PUG = PUGNAc). (b) Densitometric analysis of western blots for effects of DON and PUGNAc on O-GlcNAcylation (n = 3). n.s., not significant; p < 0.05 versus control.